Prevalence and clinical predictors of inappropriate direct oral anticoagulant dosage in octagenarians with atrial fibrillation

被引：0
|
作者：
Andreina Carbone
Francesco Santelli
Roberta Bottino
Emilio Attena
Carmine Mazzone
Valentina Parisi
Antonello D’Andrea
Paolo Golino
Gerardo Nigro
Vincenzo Russo
机构：
[1] University of Campania “Luigi Vanvitelli”,Chair of Cardiology, Department of Translational Medical Sciences
[2] Monaldi Hospital,Department of Political Sciences
[3] P.Zzale Ettore Ruggeri,Cardiovascular Centre
[4] University of Naples Federico II,Department of Translational Medical Sciences
[5] Department of Cardiology,Unit of Cardiology and Intensive Coronary Care
[6] Health Authority,undefined
[7] University of Naples Federico II,undefined
[8] Umberto I Hospital,undefined
来源：
European Journal of Clinical Pharmacology | 2022年 / 78卷
关键词：
Direct oral anticoagulant; Inappropriate dosage; Elderly; Atrial fibrillation; Stroke prevention;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：879 / 886
页数：7
相关论文
共 50 条
  • [21] Oral anticoagulant treatment in geriatric patients with nonvalvular atrial fibrillation in the era of direct oral anticoagulant agents
    Kayser, Marjorie
    Frances, Yves
    Bonello, Laurent
    Paganelli, Franck
    Peyrol, Michael
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2014, 25 (05) : E63 - E65
  • [22] Informing the Choice of Direct Oral Anticoagulant Therapy in Patients With Atrial Fibrillation
    Ferro, Enrico G.
    Kazi, Dhruv S.
    Zimetbaum, Peter J.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (23): : 2372 - 2374
  • [23] Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant
    Douketis, James D.
    Spyropoulos, Alex C.
    Duncan, Joanne
    Carrier, Marc
    Le Gal, Gregoire
    Tafur, Alfonso J.
    Vanassche, Thomas
    Verhamme, Peter
    Shivakumar, Sudeep
    Gross, Peter L.
    Lee, Agnes Y. Y.
    Yeo, Erik
    Solymoss, Susan
    Kassis, Jeannine
    Le Templier, Genevieve
    Kowalski, Stephen
    Blostein, Mark
    Shah, Vinay
    MacKay, Elizabeth
    Wu, Cynthia
    Clark, Nathan P.
    Bates, Shannon M.
    Spencer, Frederick A.
    Arnaoutoglou, Eleni
    Coppens, Michiel
    Arnold, Donald M.
    Caprini, Joseph A.
    Li, Na
    Moffat, Karen A.
    Syed, Summer
    Schulman, Sam
    [J]. JAMA INTERNAL MEDICINE, 2019, 179 (11) : 1469 - 1478
  • [24] Ximelagatran: Oral direct thrombin inhibition as anticoagulant therapy in atrial fibrillation
    Halperin, JL
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (01) : 1 - 9
  • [25] Sex disparities for patients with atrial fibrillation in the direct oral anticoagulant era
    Ishiguchi, Hironori
    Liu, Yang
    Lip, Gregory Y. H.
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2024, 54 (01)
  • [26] Apixaban: a new direct oral anticoagulant for stroke prevention in atrial fibrillation
    Hohnloser, Stefan H.
    [J]. EUROPEAN HEART JOURNAL, 2014, 35 (28) : 1828 - 1829
  • [27] Which Oral Anticoagulant for Atrial Fibrillation?
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2016, 58 (1492): : 45 - 46
  • [28] Choice of an Oral Anticoagulant in Atrial Fibrillation
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2012, 54 (1400): : 79 - 80
  • [29] Prevalence and Predictors of Left Atrial Appendage Thrombus in Non-vitamin K Oral Anticoagulant Users With Nonvalvular Atrial Fibrillation and Flutter
    Shah, Maulin
    Mobaligh, Neigena
    Niku, Adam
    Shiota, Takahiro
    Siegel, Robert J.
    Rader, Florian
    [J]. CIRCULATION, 2019, 140
  • [30] Prevalence and predictors of inappropriate DOAC prescription on first attendance at a dedicated atrial fibrillation clinic
    Suleiman, S.
    Coughlan, J. J.
    Waters, M.
    Collins, R.
    Moore, D.
    [J]. EUROPEAN HEART JOURNAL, 2021, 42 : 570 - 570
12345